Alzheimer's Disease (AD) remains a formidable challenge due to its complex pathology,
notably involving mitochondrial dysfunction and dysregulated microRNA (miRNA) signaling …

Alzheimer's disease (AD) is one of the most complicated progressive neurodegenerative
brain disorders, affecting millions of people around the world. Ageing remains one of the …

Background: Schizophrenia is a complex mental disorder with a high heritability.
Dysfunction of the N-methyl-D-aspartate (NMDA)-type glutamate receptors may be involved …

The posterior cingulate cortex, a key hub of the default mode network, underlies
autobiographical memory retrieval and displays hypometabolic changes early in Alzheimer …

Doxorubicin (DOX) is an antitumor drug that is powerful but can cause worse outcomes,
including nephrotoxicity, and therefore has limited clinical use. Therefore, it is necessary to …

Background Hepatocellular carcinoma (HCC) is the most common type of primary liver
cancer, occurring mostly in individuals with chronic liver disease, but biomarkers for …

Alzheimer's disease (AD) is a prevalently neurodegenerative disease characterized by
neuronal damage which is associated with amyloid-β (Aβ) accumulation. Hederagenin is a …

Alzheimer's disease (AD) is a complex multifactorial neurodegenerative disease
characterized by progressive memory loss. The main pathological features of the disease …

Glutamate in monosodium glutamate (MSG), which is widely used in the food industry, has
an important role in major brain functions such as memory, learning, synapse formation, and …

Background: Research reported exercise could reduce Alzheimer's disease (AD) symptoms
in human and animals. However, the molecular mechanism of exercise training via …